Join us on LinkedIn for the latest news.

Upwards arrow: Go back to top
Partner

Dr. Marianne Mertens

  • Marianne joined Apollo as a partner in 2021 and represents the Fund on the Boards of Haya Therapeutics, Auron, Booster and Cleara Therapeutics.
  • She has more than ten years of experience in the life science industry spanning venture investing, strategy consulting and research. She previously led investments into a number of life sciences companies including Confo Therapeutics, Imcheck Therapeutics and Cardior Therapeutics as a Principal with Wellington Partners and as an Investment Manager at HTGF and represented the investors at the board level.
  • Before joining the life sciences team of High-Tech Gründerfonds she worked as a management consultant, supporting pharmaceutical and medical technology companies
  • Marianne obtained a Bachelor’s and Master’s degree with distinction in Biotechnology from the RWTH Aachen University and The Scripps Research Institute, and conducted her PhD research focusing on the molecular imaging of cardiac regenerative medicines, where her research has been honored with several awards

  • Marianne joined Apollo as a partner in 2021 and represents the Fund on the Boards of Haya Therapeutics, Auron, Booster and Cleara Therapeutics.
  • She has more than ten years of experience in the life science industry spanning venture investing, strategy consulting and research. She previously led investments into a number of life sciences companies including Confo Therapeutics, Imcheck Therapeutics and Cardior Therapeutics as a Principal with Wellington Partners and as an Investment Manager at HTGF and represented the investors at the board level.
  • Before joining the life sciences team of High-Tech Gründerfonds she worked as a management consultant, supporting pharmaceutical and medical technology companies
  • Marianne obtained a Bachelor’s and Master’s degree with distinction in Biotechnology from the RWTH Aachen University and The Scripps Research Institute, and conducted her PhD research focusing on the molecular imaging of cardiac regenerative medicines, where her research has been honored with several awards